Your browser doesn't support javascript.
loading
Oral and intravenous 1'-cyano-substituted adenosine-like antivirals for early COVID-19.
Gottlieb, Robert L; Paredes, Roger.
Afiliação
  • Gottlieb RL; Center for Advanced Heart and Lung Disease, Baylor University Medical Center, Dallas, TX 75246, USA; Baylor Scott & White Research Institute, Dallas, TX, USA; Texas A&M Health Science Center, Dallas, TX, USA; Burnett School of Medicine at TCU, Fort Worth, TX, USA. Electronic address: robert.gottlieb@bswhealth.org.
  • Paredes R; Department of Infectious Diseases & Fundació Lluita contra les Infeccions, Hospital Universitari Germans Trias i Pujol, Badalona, Catalonia, Spain; IrsiCaixa AIDS Research Institute, Badalona, Catalonia, Spain; Center for Global Health & Diseases, Department of Pathology, Case Western Reserve University, Cleveland, OH, USA.
Lancet Infect Dis ; 24(2): 108-110, 2024 Feb.
Article em En | MEDLINE | ID: mdl-38006893

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Adenosina / COVID-19 Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Adenosina / COVID-19 Idioma: En Ano de publicação: 2024 Tipo de documento: Article